Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Mining_Dudeon May 16, 2018 7:48pm
109 Views
Post# 28042686

RE:Share Structure matters

RE:Share Structure mattersI disagree that EPS will rule the day.  Almost every analyst's go-to metric is is EV/EBITDA in this space, I dont really see that changing...

mcha20000000000 wrote: Absolutely no other Canadian LP is diluting at the rate ACB is.

You can have all the capacity in the world (which has been one of the main focusing factors so far), but if costs are out of wack, if there's a lack of supply deals, and if you spent too much on the assets you acquired then you are going to run into a problem. 

Fully diluted this puts them at slightly over 1b shares. This assumes no further dilution is needed to build Aurora Sun as well. EPS will rule the day in the end, and if earnings won't be increasing at the same rate as their recent share issuance, then it will ultimately stunt their share price growth compared to other Canadian LPs.


Bullboard Posts